Performance, clinical utility, and cost-effectiveness of selective use of staging investigations in early breast cancers.

Selective use of SI results in better yield. However, the clinical utility of these results is not significant. It is debatable if this level of expenditure is cost-effective. Our results point to a need for change in practice.